Eric R. Braverman

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search
Eric R. Braverman, M.D.
Nationality American
Alma mater Brandeis University; New York University School of Medicine
Scientific career
Institutions PATH Medical
Website www.pathmed.com

Eric R. Braverman is a physician, researcher, and author. He is the medical director of PATH (Place for Achieving Total Health) Medical and coordinator of clinical research for PATH Foundation NY, both of which are located in New York City.

Education[edit]

Braverman earned his undergraduate degree from Brandeis University in 1979 and his medical degree from New York University School of Medicine in 1983, and did subsequent residency and research at Greenwich Hospital and Massachusetts General Hospital.[1]

Career[edit]

Braverman has served as clinical assistant professor of integrative medicine in neurological surgery at Weill Cornell Medical College (2008–2013), assistant attending physician at Cabrini Medical Center, and instructor in psychiatry at New York University School of Medicine.[2] He holds an appointment as Courtesy Assistant Professor at the University of Florida.[3]

Braverman is the founder and medical director of the Place For Achieving Total Health (PATH) Medical where his focus is brain health,[4][5] and he promotes the use of hormone replacement therapy and dietary supplements.[6]

PATH Medical has been investigated by the Office of the New York State of the Attorney General Health Care Bureau for deceptive and misleading business practices due to a large number of complaints to the OAG and disputes with credit card companies. The OAG found that PATH Medical had misrepresented the cost of treatment to patients by claiming insurance would cover as much as 80% of the cost of treatment, even while PATH Medical was aware that insurance was likely to deny claims. The OAG also found that patients were not provided documentation about what testing had been conducted at the time of treatment, and that many patients complained that they were being charged extra to review or discuss the results of those tests. Finally, the OAG found that PATH Medical used insecure methods such as personal email accounts to communicate private health information, including patient records. PATH Medical reached a settlement with the NY OAG in December 2014, called Assurance 14-222, promising to reform its practices to ensure that all consent forms would clearly indicate that patients will likely not receive insurance coverage for their treatment, that patients would receive an itemized receipt with costs and CPT codes before any treatment is conducted, and that PHI would no longer be sent via email.[7]

Braverman is a member in other professional societies including the American Academy of Anti-Aging Medicine, the American Society of Bariatric Physicians, the American Neuropsychiatric Association, the Quantitative EEG Board, and the American Society of Addiction Medicine.[8][9]

Publications[edit]

References[edit]

  1. ^ "Anti-Ageing Conference London 2004 Speaker Biography". Antiagegingconference.com. Retrieved 2012-06-20. 
  2. ^ "Guest Detail – Eric Braverman, MD". VoiceAmerica.com. Retrieved 2012-06-20. 
  3. ^ "Healthy Aging and Society: New Course Transmittal Form" on the University of Florida website. Accessed: June 19, 2014
  4. ^ Davidovit, Aliza, "Dr. Eric Braverman" (PDF), Lifestyles Magazine, pp. 28–31, archived from the original (PDF) on 2012-01-31, retrieved 2012-06-20 
  5. ^ Caruso, Donna (March 2007), "Wellness Profile: Breakthroughs to Create a 'Younger You'", Life Extension Magazine, retrieved 2012-06-20 
  6. ^ Kiefer, Dale (March 2008), "Brave New World: Dr. Eric Braverman's Path to Earlier Detection and Treatment of Cognitive Decline", Life Extension Magazine, retrieved 2012-06-20 
  7. ^ "Assurance 14-222" (PDF). Nyag-2014.pdf. Casewatch.org. December 2014. Retrieved 10 December 2015. 
  8. ^ "Fellowship in Anti-Aging Regenerative & Functional Medicine – Staff and Faculty". Faafm.com. Archived from the original on 2012-06-19. Retrieved 2012-06-20. 
  9. ^ Jancin, Bruce (2011-04-14), "P300 Evoked Potential May Identify Early Brain Deterioration", Internal Medicine News, Internalmedicinenews.com, archived from the original on 2014-01-04, retrieved 2012-06-20 

External links[edit]